Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
CA 2457644 A1 · Owner: Yamada, Masashi · Inventors: Iinuma, Munekazu; Tanaka, Toshiyuki; Yamada, Masashi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The objective of the present invention is to identify compounds having an inhibitory effect on adipocyte differentiation and to provide pharmaceutical , compositions and food compositions for prevention improvement, or treatment , of obesity or obesity related diseases. By enthusiastically studying natural products that inhibit the differentiation induction of adipocyte precursors into adipocytes, sesquiterpenoid derivatives which are extracts from a , Compositae plant Calea, growing in Central and South America were , demonstrated to have an excellent inhibitory effect on adipocyte differentiation induction. Calea extract or the sesquiterpenoid derivatives are expected to be used in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 9, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.